News | News By Subject | News by Disease News By Date | Search News

Influenza News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AstraZeneca PLC (AZN) Takes a $80 Million Hit as the CDC Says Flu Vaccine Flumist Does Not Work     6/23/2016
Vaxart Pins Hopes on Oral Zika and Flu Virus Vaccines     3/25/2016
Valeant (VRX) Accused of Hiding Cold Drug Study Results Proving Drug Was No More Effective than a Placebo     2/3/2016
Visterra, Inc. Awarded Contract Valued at Up to $204.5 Million     10/5/2015
Novartis AG (NVS) Researchers ID Possible Link Between GlaxoSmithKline (GSK) Flu Vaccine, Narcolepsy     7/6/2015
GlaxoSmithKline (GSK) Recalls Flu Vaccine Over Potency Issues     4/21/2015
Why the Flu Vaccine Barely Worked This Year     4/8/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015     2/10/2015
New Study Vindicates Efficacy of Roche (RHHBY)'s Blockbuster Drug Tamiflu     2/2/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)     1/28/2015
Achillion Pharmaceuticals, Inc. (ACHN) Surges as Potential Drug Combo Seen as Hepatitis C Cure     12/23/2014
FDA Approves Biocryst Pharmaceuticals (BCRX)'s Intravenous Flu Drug Rapivab     12/22/2014
EXCLUSIVE: Sanofi Pasteur (SASY.PA) US CMO Says U.S. Regulators Most Interested in Four-Strain Flu Vax     12/18/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014

News from Around the Web
New, More Effective Flu Vaccine Delivered Using Dissolvable Microneedle Patch, Georgia State University Study     7/24/2017
Science May Just Have Found A Way To Treat The Flu And Common Cold, Nature Communications Reveals     7/13/2017
Skin Patch May Be The Future Of Flu Vaccines, Lancet Reveals     6/28/2017
New Flu Test Easy As Breathing, With Faster Results, KTH Royal Institute of Technology Reveals     3/29/2017
A Bit More Vitamin D May Stop Colds And Flu, Queen Mary University of London Study     2/16/2017
Lots Of Us Are Sick, And It's Probably Going To Get Worse. Here's Why     1/9/2017
Why It’s Time For A Rethink On Flu Vaccination     11/21/2016
The $5.8 Billion Hidden Cost Of The Flu On The U.S. Economy     10/31/2016
The Top 4 Flu Treatments That Do Not Work (And 2 That Do)     10/26/2016
Man’s Best Friend May Be The Flu’s Worst Enemy, University of Hong Kong Study     9/30/2016
MedImmune (AZN)'s Flumist Vaccine Just Got Another Thumbs Down. This Time It's A Pediatricians Group     9/13/2016
Interferon Shows Promise As Flu Therapy, Francis Crick Institute in London Study     9/7/2016
Your Weight Could Make The Flu Shot Less Effective, WHO Reveals     8/8/2016
What's Going On With The Nasal FluMist Vaccine? CDC Reveals     6/28/2016
Flu Vaccine May Lower Dementia Risk In Heart Failure Patients, Taipei Medical University Study     5/24/2016

Press Releases
Altimmune Announces its Phase II Flu Vaccine Trial With NasoVAX Open For Enrollment     9/20/2017
Novavax (NVAX) Initiates Phase I/II Trial Of Nanoflu Vaccine In Older Adults     9/19/2017
InDevR Licenses Mount Sinai Influenza Antibodies For VaxArray Neuraminidase Potency Assay     9/19/2017
Shionogi Release: S-033188 Phase III CAPSTONE-1 Study Results For Treatment Of Influenza Presented At The European Scientific Working Group On Influenza Conference     9/13/2017
Prommune Announces Results Of A Study On Its Lead Products, Heptavac And HISP-P For Use In Pigs With Swine Influenza Virus Infections     8/25/2017
Novavax (NVAX)’ Preclinical Influenza Nanoparticle Study Published In Vaccine     8/23/2017
Altimmune Submits Investigational New Drug Application For Nasovax In Preparation For Phase II Trial     8/21/2017
Hemispherx (HEB) Human Safety Study Of Intranasal Ampligen With Influenza Vaccine Shows Ampligen Was Generally Well-Tolerated     8/14/2017
Shionogi Announces Positive Top-Line Results For S-033188 Phase III Study (CAPSTONE-1) In Otherwise Healthy Influenza Patients     7/24/2017
BiondVax's Universal Flu Vaccine Meets All Endpoints in Phase IIb Study     7/20/2017
Seqirus Begins Shipping 2017-2018 Influenza Vaccines To The U.S. Market     7/20/2017
BiondVax Pharmaceuticals Signs Lease Agreement For Mid-Size Commercial Facility To Manufacture Universal Flu Vaccine     7/18/2017
Sanofi Pasteur (SASY.PA) Ships First Of Its U.S. Influenza Vaccine Doses For 2017-2018 Season     7/17/2017
Inovio Pharma (INO)’s DNA-Based Monoclonal Antibody Platform Achieves Further Proof-Of-Principle Validation     7/6/2017
Hologic (HOLX)'s New Panther Fusion System, Flu And Respiratory Assays Now CE Marked In Europe     6/29/2017